FTC’s “Authorized” Generics Study Should Have Greater “Qualitative” Focus, GPhA Says
This article was originally published in The Pink Sheet Daily
PhRMA, however, contends FTC’s information collection proposal “lacks practical utility” and instead should include more quantitative data.
You may also be interested in...
FTC is planning to survey approximately 190 firms, but seeks comments on how to reduce the number without undermining the study’s validity.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles